Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03502317
Other study ID # 17-0185
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 14, 2018
Est. completion date March 31, 2021

Study information

Verified date February 2020
Source Mount Sinai Hospital, Canada
Contact Emily Taylor
Phone 416-586-4800
Email emily.taylor@sinaihealthsystem.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized control trial aiming to investigate the use of a prehabilitation regimen for patients undergoing major GI cancer surgery and its effects on measurements of HRQOL, LOS, and post-operative complications. Participants will be randomized to either the Prehabilitation arm or the Usual Care arm (control group). The Prehabilitation arm will be prescribed both physical and psychological prehabilitation prior to undergoing surgery for their GI cancer. The Usual Care arm will be counseled to continue their current level of activity and given the information on exercise as outlined in the Cancer Care Ontario guidelines. Participants in the Usual Care arm will also be given the same activity tracker as patients in the Prehabilitation arm in order to eliminate the activity tracker as an intervention itself. Clinical, patient-reported outcomes and health system outcomes will be evaluated. Outcomes will be measured at consent (baseline), immediately preoperatively, and postoperatively at 1, 3 and 6 months. The investigators will collect measures of recruitment, attrition and self-reported compliance via a log completed by the coordinator during weekly patient phone calls.


Recruitment information / eligibility

Status Recruiting
Enrollment 128
Est. completion date March 31, 2021
Est. primary completion date August 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- = 18 years of age

- Fluent in English

- Able to comply with study procedures & follow-up contained within the consent form

- Pathologically or radiologically confirmed diagnosis of a GI cancer

- GI cancer must be considered operable

- Expected LOS = 5 days as calculated by the validated American College of Surgeons Surgical Risk Calculator

- > 21 days between time of randomization and time of expected surgery

- Patient written, informed consent obtained according to ICH GCP guidelines and local regulations

Exclusion Criteria:

- < 18 years old

- Not fluent in English

- Planned resection of bony pelvis, limbs, or major lower extremity neurovascular structures

- Significant comorbidity including any of the following:

- Canadian Cardiovascular Society class III/IV coronary disease

- New York Heart Association class III/IV congestive heart failure

- Neurologic or musculoskeletal disorder prohibiting exercise

- Major neuropsychiatric disorder

Study Design


Intervention

Behavioral:
Physical Prehabilitation
Physical prehabilitation will comprise a personalized, home-based exercise program designed to meet the Cancer Care Ontario Exercise Guidelines for Cancer Survivors. A Registered Kinesiologist (RKin) will complete a baseline physical assessment and prescribe an individualized multi-modal exercise program consisting of 4-5 days of 30+ minutes of aerobic exercise (brisk walking or equivalent to target heart rate of 40-60% of max) and 2-3 days of moderate intensity resistance training of major muscle groups (8-10 repetitions). Participants will be provided with a Fitbit with a heart rate monitor, resistance bands, and a stability ball. Patients will be required to wear their Fitbit and record the number of steps at the end of each day from randomization to 90 days post-surgery.
Psychological Prehabilitation
Psychological prehabilitation will consist of one in-person coaching session of a 'mindfulness' informed intervention conducted by a specially trained RKin. The 40 minute coaching session will include a guided mindfulness session and debriefing. Participants will be asked to practice for 20 minutes twice a day. The patients will be given access to an audio file that will walk them through the 20 minute sessions.

Locations

Country Name City State
Canada Sinai Health System - Mount Sinai Hospital Toronto Ontario
Canada University Health Network Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
Mount Sinai Hospital, Canada University Health Network, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Global Health Score The primary outcome is the difference between the baseline and 90-day global health score on the European Organization for the Research and Treatment of Cancer (EORTC) QLC-C30 Baseline to postoperative day 90
Secondary Presence and severity of postoperative complications The presence and severity of postoperative complications at 30 and 90 days will be recorded from the patient's medical records Postoperatively through to day 30 and day 90
Secondary Postoperative hospital length of stay The patient's postoperative length of stay will be recorded from the medical records Length of stay will be calculated from the date of surgery until to the date of discharge from the hospital, reported in days, assessed up to 6 months postoperatively.
Secondary Changes in functional capacity from baseline Patients will perform a 6-Minute Walk Test. Baseline, immediately preoperatively, and postoperatively at 1, 3, and 6 months
Secondary Changes in self-reported physical activity from baseline Changes in self-reported physical activity will be measured using the Godin Leisure-time Exercise Questionnaire Baseline, immediately preoperatively, and postoperatively at 1, 3, and 6 months
Secondary Changes in health-related quality of life from baseline HRQOL will be measured using the EQ-5D Health Questionnaire Baseline, immediately preoperatively, and postoperatively at 1, 3, and 6 months
Secondary Presence and severity of symptoms The presence and severity of nine common symptoms in cancer patients will be examined using the Edmonton Symptom Assessment Scale (ESAS). This self-report measure examines: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, wellbeing, and shortness of breath. Baseline, immediately preoperatively, and postoperatively at 1, 3, and 6 months
Secondary Changes in anxiety and depression from baseline Changes in anxiety and depression will be examined using the Hospital Anxiety and Depression Scale (HADS). HADS assesses anxiety and depression through self-reporting based on the frequency of symptoms over the past week. There are 2 subscales, one for anxiety and for depression, each with 7 items. Items are scored on a 4 point Likert scale (0-3), with the subscale scores being sums of each item (0-21). A higher score is indicative of higher or worse anxiety and depression. Baseline, immediately preoperatively, and postoperatively at 1, 3, and 6 months
Secondary Changes in fatigue from baseline Changes in cancer-specific fatigue will be assessed using the 13-item Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F). Baseline, immediately preoperatively, and postoperatively at 1, 3, and 6 months
Secondary Interference with occupational performance and productivity The degree to which the patient's health problems interfere with occupational performance and productivity will be examined using the Work Limitations Questionnaire Baseline, immediately preoperatively, and postoperatively at 1, 3, and 6 months
Secondary Changes in multidimensional social support Changes in the perceived availability of multidimensional social support will be evaluated using the Medical Outcomes Study Social Support Scale (MOS-SSS SF-20). The MOS-SSS SF-20 is a 20 item questionnaire that measures physical functioning, social functioning, mental health, current health perceptions, and pain. After reverse scoring of the appropriate items according to the MOS-SSS core scoring manual, a higher value indicates better functioning, health, and more pain in the respective measures. All measure scores are transformed linearly to scales from 0-100, with 100 being the highest score possible. Baseline, immediately preoperatively, and postoperatively at 1, 3, and 6 months
Secondary Changes in attachment (closeness in relationships with others) The Experiences in Close Relationships Scale (ECR M16) will be used to examine adult attachment or closeness in both romantic and non-romantic relationships. There are two domains that are measured - attachment anxiety and avoidance. Each domain includes 8 items. Items are scored on a 7 point Likert Scale (1-7). After appropriate reverse scoring, a high score indicates higher attachment anxiety or avoidance. Baseline, immediately preoperatively, and postoperatively at 1, 3, and 6 months
Secondary Health care utilization Health care utilization will be assessed at the postoperative 3 and 6 month time points using the Health Service Utilization Inventory post-operatively at 3 and 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT03213314 - HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies N/A
Enrolling by invitation NCT05534490 - Surgery and Functionality in Older Adults N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT04612491 - Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
Recruiting NCT06397287 - PROM Project Urology
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03432429 - Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Recruiting NCT05370404 - Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain: N/A
Not yet recruiting NCT05467319 - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Phase 3
Recruiting NCT04602429 - Children's Acute Surgical Abdomen Programme
Completed NCT03124901 - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor N/A
Completed NCT04595695 - The Effect of Clear Masks in Improving Patient Relationships N/A
Recruiting NCT06103136 - Maestro 1.0 Post-Market Registry
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04059328 - Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A
Completed NCT03355547 - Observation of Atelectasis Using Lung Ultrasonography in Children Undergoing General Anesthesia: the Cohort Study for Evaluation of the Relationship Between the Incidence and Severity of Upper Respiratory Tract Infection and the Magnitude of Anesthesia-induced Atelectasis